Viswanath Das

12PUBLICATIONS
21CO-AUTHORS
Biomolecular modelling and designMolecular targetsCheminformatics and quantitative structure-activity relationshipsMedical infection agents (incl. prions)Neurology and neuromuscular diseases
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (12)

|Sep 12, 2026
Design, synthesis, molecular docking and anticancer activity of novel N-(4-(chlorodifluoromethoxy)phenyl)-1H-pyrrolo[2,3-b]pyridine-5-carboxamide derivatives.

|Mar 12, 2026
Oncology drug repurposing as a blueprint for Alzheimer's therapy.

Viswanath Das, Marián Hajdúch

|Dec 08, 2025
Design, synthesis, and biological evaluation of novel 3-oxo-2,3-dihydropyridazine derivatives as interleukin-2-inducible T-cell kinase (ITK) inhibitors.

Sudhakar Tangallapalli, Rambabu Gundla, Kalyani Paidikondala

|Aug 27, 2025
Structural and functional insights into the selective inhibition of mutant tau aggregation by purpurin and oleocanthal in frontotemporal dementia.

Alladi Charanraj Goud, Ihor Kozlov, Patricie Skoupilová

|Aug 17, 2025
Hydrophobic residues in the α-synuclein NAC domain drive seed-competent fibril formation and are targeted by peptide inhibitors.

Viswanath Das, Sayed Mostafa Modarres Mousavi, Narendran Annadurai

|Mar 26, 2024
Antineoplastics for treating Alzheimer's disease and dementia: Evidence from preclinical and observational studies.

Viswanath Das, John H Miller, Charanraj Goud Alladi

Pageof 2

Frequent Collaborators

2 joint publications

Bohumír Grüner

2 joint publications

Jan Nekvinda

2 joint publications

Rambabu Gundla

2 joint publications

Marián Hajdúch